AUBAGIO vs BRIUMVI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. AUBAGIO and BRIUMVI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AUBAGIO	BRIUMVI
Rating	70/100	New
Pharmacy pays	~$16.32 /30	—
Type	RX	RX
Active ingredient	TERIFLUNOMIDE	UBLITUXIMAB-XIIY
Manufacturer	Sanofi Aventis US	Tg Therapeutics, Inc
Dosage forms	Tablet	Injectable
Drug class	Pyrimidine Synthesis Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Relapsing-Remitting Multiple Sclerosis	Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

aubagio briumvi

Rating

70/100

New

Pharmacy pays

~$16.32 /30

—

Type

Active ingredient

TERIFLUNOMIDE

UBLITUXIMAB-XIIY

Manufacturer

Sanofi Aventis US

Tg Therapeutics, Inc

Dosage forms

Tablet

Injectable

Drug class

Pyrimidine Synthesis Inhibitor

—

Boxed warning

None

Treats

Relapsing-Remitting Multiple Sclerosis

Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

What is the difference between Aubagio and Briumvi?

Aubagio contains Teriflunomide, while Briumvi contains Ublituximab-Xiiy — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.